{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Amsilarotene",
  "nciThesaurus": {
    "casRegistry": "125973-56-0",
    "chebiId": "",
    "chemicalFormula": "C20H27NO3Si2",
    "definition": "A retinobenzoic acid with potential antineoplastic activity. Amsilarotene inhibits retinoblastoma-gene product (RB) phosphorylation and increases the presence of 2 cyclin-dependent kinase (CDK) inhibitors, resulting in cell cycle arrest.  This agent also causes a cytotoxic decline in cyclin A and thymidylate synthase expression.",
    "fdaUniiCode": "Q1418F39MH",
    "identifier": "C38684",
    "preferredName": "Amsilarotene",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C804"
    ],
    "synonyms": [
      "AMSILAROTENE",
      "Amsilarotene",
      "TAC 101",
      "TAC-101"
    ]
  }
}